Search research articles
Contact Us
Filters
Showing results (111-120 of 162) with videos related to
Page
of 17
Sort By:
International Journal of MS Care
|
March 7, 2018
Projecting the Adequacy of the Multiple Sclerosis Neurologist Workforce
Michael T Halpern, Heather Kane, Stephanie Teixeira-Poit, et al.
World Neurosurgery
|
May 24, 2024
Operative Epidemiology of the First Five Years in a New African Neurosurgery Training Center: The Experience in Rural Kenya at Tenwek Hospital 2016 to 2021
Ndaro Daniel Bulenga, Aaron Miller, Ben Ojakapeli, et al.
Magnetic Resonance in Medicine
|
January 4, 2026
Dynamic RBC-To-Membrane Ratio in <sup>129</sup>Xe MRI: A Biomarker of Decreased Lung Function in Pulmonary and Vascular Diseases
Gabriela María García Delgado, Ummul Afia Shammi, Cody Thornburgh, et al.
Plos One
|
April 25, 2017
Cerebellar volume as imaging outcome in progressive multiple sclerosis
Matilde Inglese, Maria Petracca, Enricomaria Mormina, et al.
Aging Cell
|
May 26, 2016
Chemical activation of a food deprivation signal extends lifespan
Mark Lucanic, Theo Garrett, Ivan Yu, et al.
Neurology
|
February 12, 2016
Recommendations for observational studies of comorbidity in multiple sclerosis
Ruth Ann Marrie, Aaron Miller, Maria Pia Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 20, 2016
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Maria Petracca, Christian Cordano, Maria Cellerino, et al.
The New England Journal of Medicine
|
October 14, 2011
Randomized trial of oral teriflunomide for relapsing multiple sclerosis
Paul O'Connor, Jerry S Wolinsky, Christian Confavreux, et al.
Melanoma Research
|
December 16, 2020
Novel response to neoadjuvant anti-PD1 therapy for a patient with retrocaval melanotic schwannoma
Charles C Vining, Phillip J Hsu, Aaron Miller, et al.
Multiple Sclerosis and Related Disorders
|
February 18, 2025
Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trials
Ralph Hb Benedict, Ludwig Kappos, Aaron Miller, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 162) with videos related to
Sort By:
Page
of 17
International Journal of MS Care
|
March 7, 2018
Projecting the Adequacy of the Multiple Sclerosis Neurologist Workforce
Michael T Halpern, Heather Kane, Stephanie Teixeira-Poit, et al.
World Neurosurgery
|
May 24, 2024
Operative Epidemiology of the First Five Years in a New African Neurosurgery Training Center: The Experience in Rural Kenya at Tenwek Hospital 2016 to 2021
Ndaro Daniel Bulenga, Aaron Miller, Ben Ojakapeli, et al.
Magnetic Resonance in Medicine
|
January 4, 2026
Dynamic RBC-To-Membrane Ratio in <sup>129</sup>Xe MRI: A Biomarker of Decreased Lung Function in Pulmonary and Vascular Diseases
Gabriela María García Delgado, Ummul Afia Shammi, Cody Thornburgh, et al.
Plos One
|
April 25, 2017
Cerebellar volume as imaging outcome in progressive multiple sclerosis
Matilde Inglese, Maria Petracca, Enricomaria Mormina, et al.
Aging Cell
|
May 26, 2016
Chemical activation of a food deprivation signal extends lifespan
Mark Lucanic, Theo Garrett, Ivan Yu, et al.
Neurology
|
February 12, 2016
Recommendations for observational studies of comorbidity in multiple sclerosis
Ruth Ann Marrie, Aaron Miller, Maria Pia Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 20, 2016
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Maria Petracca, Christian Cordano, Maria Cellerino, et al.
The New England Journal of Medicine
|
October 14, 2011
Randomized trial of oral teriflunomide for relapsing multiple sclerosis
Paul O'Connor, Jerry S Wolinsky, Christian Confavreux, et al.
Melanoma Research
|
December 16, 2020
Novel response to neoadjuvant anti-PD1 therapy for a patient with retrocaval melanotic schwannoma
Charles C Vining, Phillip J Hsu, Aaron Miller, et al.
Multiple Sclerosis and Related Disorders
|
February 18, 2025
Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trials
Ralph Hb Benedict, Ludwig Kappos, Aaron Miller, et al.
Page
of 17